Literature DB >> 17130277

New-onset diabetes after kidney transplantation: risk factors.

Emilio Rodrigo1, Gema Fernández-Fresnedo, Rosalía Valero, Juan Carlos Ruiz, Celestino Piñera, Rosa Palomar, Julio González-Cotorruelo, Carlos Gómez-Alamillo, Manuel Arias.   

Abstract

New-onset diabetes after transplantation (NODAT) contributes to the risk for cardiovascular disease and infection, reducing graft and patient survival. For improvement of the outcome of kidney transplant recipients, it is of great interest to know precisely the risk factors that contribute to NODAT development. Nonmodifiable risk factors for development of NODAT are age, race, genetic background, family history of diabetes, and previous glucose intolerance. Modifiable risk factors are obesity and overweight, hepatitis C virus and cytomegalovirus infections, and immunosuppressive drugs. Both steroids and calcineurin inhibitors influence the appearance of NODAT, whereas the role of sirolimus in glucose metabolism currently is controversial.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130277     DOI: 10.1681/ASN.2006080929

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  46 in total

1.  Left ventricular torsion changes post kidney transplantation.

Authors:  Yan Deng; Anil Pandit; Raymond L Heilman; Harini A Chakkera; Marek J Mazur; Farouk Mookadam
Journal:  J Cardiovasc Ultrasound       Date:  2013-12-27

Review 2.  New developments in the management of cytomegalovirus infection after solid organ transplantation.

Authors:  Albert J Eid; Raymund R Razonable
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

3.  Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation.

Authors:  Luisa M Rodríguez; Richard J Knight; Rubina A Heptulla
Journal:  Diabetes Technol Ther       Date:  2010-05       Impact factor: 6.118

4.  Ghrelin contributes to derangements of glucose metabolism induced by rapamycin in mice.

Authors:  G Xu; Z Wang; Y Li; Z Li; H Tang; J Zhao; X Xiang; L Ding; L Ma; F Yuan; J Fei; W Wang; N Wang; Y Guan; C Tang; M Mulholland; W Zhang
Journal:  Diabetologia       Date:  2012-03-03       Impact factor: 10.122

Review 5.  New-onset diabetes mellitus after kidney transplantation: Current status and future directions.

Authors:  Sneha Palepu; G V Ramesh Prasad
Journal:  World J Diabetes       Date:  2015-04-15

6.  Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients.

Authors:  Tracy L Lemonovich; Richard R Watkins
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 7.  Metabolic Disorders with Kidney Transplant.

Authors:  Elizabeth Cohen; Maria Korah; Glenda Callender; Renata Belfort de Aguiar; Danielle Haakinson
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-13       Impact factor: 8.237

8.  Pre-transplant weight but not weight gain is associated with new-onset diabetes after transplantation: a multi-centre cohort Spanish study.

Authors:  Domingo Marrero; Domingo Hernandez; Lourdes Pérez Tamajón; Manuel Rivero; Ildefonso Lampreabe; Maria Dolores Checa; Jose Manuel Gonzalez-Posada
Journal:  NDT Plus       Date:  2010-06

9.  A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation.

Authors:  Michael Haidinger; Johannes Werzowa; Hans-Christian Voigt; Johannes Pleiner; Gunar Stemer; Manfred Hecking; Dominik Döller; Walter H Hörl; Thomas Weichhart; Marcus D Säemann
Journal:  Trials       Date:  2010-10-06       Impact factor: 2.279

10.  Obesity impacts access to kidney transplantation.

Authors:  Dorry L Segev; Christopher E Simpkins; Richard E Thompson; Jayme E Locke; Daniel S Warren; Robert A Montgomery
Journal:  J Am Soc Nephrol       Date:  2007-12-19       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.